Weizmann Experimental Blood Test Identifies Early Breast Cancer in Study Samples
Text
Molecular markers offer a detection route.
Weizmann reports 95% accuracy identifying early breast cancer with an experimental blood test in study samples.
Researchers retrospectively analyzed samples from 77 patients and 30 healthy women, training AI to distinguish the groups.
The test reads molecular tags on DNA-packaging proteins released into blood, looking for cancer-associated patterns.
These are research-sample results. Population screening requires further validation; the method remains experimental.
Original source published: Weizmann Institute, November 11, 2026
Share this article
What do you think of this story?
Anonymous feedback, up to 5 reactions per article.
Anonymous comments
Share your thoughts without signing in.
Discuss the technology and the story. Hate, politics and war, threats, abuse, personal accusations, sexual content, ads, links and personal information are not allowed.
No comments yet. Be the first to share.